N
NVO
Novo-Nordisk A/S
56.46
0.35+0.62%After Hours: 56.45 -0.01 -0.02%19:59 08/29 EDT
OPEN/PREV CLOSE56.05/56.11
TODAY RANGE55.71-56.53
VOL9.12M
MARKET CAP250.63B
52 WEEK RANGE44.55-135.90
AVG VOL (3M)15.49M
% TURNOVER0.21%
TURNOVER--
P/E (TTM)14.35
% RANGE1.45%
EPS(TTM)3.935
P/E(FORWARD)15.75
P/B9.46
BVPS5.97
DIVIDEND1.727
P/S6.22
BETA--
DIV YIELD3.06%
FREE FLOAT MKT CAP250.62B
SHARES OUTSTANDING4.44B
NEXT EARNINGS--
FREE FLOAT4.44B
LOT SIZE1
EX-DATE08/18/2025
News
Press Releases
Financial Reports
Profile
Benzinga·9h ago
Novo Nordisk Slowdown Weighs On Denmark's Economic Outlook
TipRanks·13h ago
Novo Nordisk (0QIU) Gets a Hold from UBS
Seeking Alpha·14h ago
Denmark cuts growth forecast amid troubles for Novo Nordisk
Seeking Alpha·1d ago
Wall Street Lunch: 'Economy Is Slowing, But Still Clearly Growing'
Seeking Alpha·1d ago
Eli Lilly: In The Eye Of The Drug Pricing Storm - Expect Volatility, And Buy
Seeking Alpha·1d ago
Eli Lilly: Orals Unlock The Next Wave Of Obesity Drug Adoption
Seeking Alpha·1d ago
Teva gets FDA nod for generic version of Novo's weight loss drug
Reuters·1d ago
BUZZ-Teva rises on FDA approval for generic obesity drug
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.